Research Studies

Read more in this article

A new international study supported by Novartis and developed in partnership with the Sjögren’s community explores the real-life burden, unmet needs, and treatment experiences of people living with Sjögren’s disease.

Primary Sjögren’s is a multi-system autoimmune disease affecting patients’ physical, mental, and emotional wellbeing. The epidemiology of Sjögren’s is not well understood, and up-to-date epidemiological evidence is needed to improve knowledge and awareness of Sjögren’s among patients and healthcare professionals, and to ascertain the global burden of disease. The objective of this research was to